Conserved CPEs in the P53 3′ untranslated region influence mRNA stability and protein synthesis

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2553-2560

  Rosenstierne, Maiken W ^a   Vinther, Jeppe ^a   Mittler, Gerhard ^b   Larsen, Louise ^a   Mann, Matthias ^c   Norrild, Bodil ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

P53; Post transcriptional regulation; Protein synthesis; Regulation

Indexed keywords

CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MESSENGER RNA; PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REPORTER GENE; ULTRAVIOLET IRRADIATION; UNTRANSLATED REGION; WILD TYPE;

3' UNTRANSLATED REGIONS; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; KERATINOCYTES; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 55749093994     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555, 1994.
2. Fei P and el-Deiry WS: P53 and radiation responses. Oncogene 22: 5774-5783, 2003.
3. Iliakis G, Wang Y, Guan J and Wang H: DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22: 5834-5847, 2003.
4. Oren M, Maltzman W and Levine AJ: Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1: 101-110, 1981.
5. Rogel A, Popliker M, Webb CG and Oren M: p53 Cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 5: 2851-2855, 1985.
6. Maltzman W and Czyzyk L: UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4: 1689-1694, 1984.
7. Pluquet O and Hainaut P: Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett 174: 1-15, 2001.
8. Fritsche M, Haessler C and Brandner G: Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8: 307-318, 1993.
9. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
10. Tishler RB, Calderwood SK, Coleman CN and Price BD: Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res 53: 2212-2216, 1993.
11. Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F and Deppert W: Negative feedback regulation of wild-type p53 biosynthesis. EMBO J 14: 4442-4449, 1995.
12. Takagi M, Absalon MJ, McLure KG and Kastan MB: Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123: 49-63, 2005.
13. Ray PS, Grover R and Das S: Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep 7: 404-410, 2006.
14. Yang DQ, Halaby MJ and Zhang Y: The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene 25: 4613-4619, 2006.
15. Fu L, Minden MD and Benchimol S: Translational regulation of human p53 gene expression. EMBO J 15: 4392-4401, 1996.
16. Fu L and Benchimol S: Participation of the human p53 3′UTR in translational repression and activation following gamma-irradiation. EMBO J 16: 4117-4125, 1997.
17. Fu L, Ma W and Benchimol S: A translation repressor element resides in the 3′ untranslated region of human p53 mRNA. Oncogene 18: 6419-6424, 1999.
18. Mazan-Mamczarz K, Galbán S, López de Silanes I, Martindale JL, Atasoy U, Keene JD and Gorospe M: RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci USA 100: 8354-8359, 2003.
19. Zou T, Mazan-Mamczarz K, Rao JN, Liu L, Marasa BS, Zhang AH, Xiao L, Pullmann R, Gorospe M and Wang JY: Polyamine depletion increases cytoplasmic levels of RNA-binding protein HuR leading to stabilization of nucleophosmin and p53 mRNAs. J Biol Chem 281: 19387-19394, 2006.
20. D'Erchia AM, Pesole G, Tullo A, Saccone C and Sbisa E: Guinea-pig p53 mRNA: identification of new elements in coding and untranslated regions and their functional and evolutionary implications. Genomics 58: 50-64, 1999.
21. Groisman I, Jung MY, Sarkissian M, Cao Q and Richter JD: Translational control of the embryonic cell cycle. Cell 109: 473-483, 2002.
22. Huang YS, Jung MY, Sarkissian M and Richter JD: N-methyl-D- aspartate receptor signaling results in aurora kinase-catalyzed CPEB phosphorylation and alpha CaMKII mRNA polyadenylation at synapses. EMBO J 21: 2139-2148, 2002.
23. Huang YS, Carson JH, Barbarese E and Richter JD: Facilitation of dendritic mRNA transport by CPEB. Genes Dev 17: 638-653, 2003.
24. Mendez R and Richter JD: Translational control by CPEB: a means to the end. Nat Rev Mol Cell Biol 2: 521-529, 2001.
25. Rossi FM, Guicherit OM, Spicher A, Kringstein AM, Fatyol K, Blakely BT and Blau HM: Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Genet 20: 389-393, 1998.
26. Blagoev B, Ong SE, Kratchmarova I and Mann M: Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat Biotechnol 22: 1139-1145, 2004.
27. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A and Mann M: Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386, 2002.
28. Schulze WX and Mann M: A novel proteomic screen for peptide-protein interactions. J Biol Chem 279: 10756-10764, 2004.
29. Olsen JV and Mann M: Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation. Proc Natl Acad Sci USA 101: 13417-13422, 2004.
30. Seitz B, Baktanian E, Gordon EM, Anderson WF, LaBree L and McDonnell PJ: Retroviral vector-mediated gene transfer into keratocytes: in vitro effects of polybrene and protamine sulfate. Graefes Arch Clin Exp Ophthalmol 236: 602-612, 1998.
31. Spicher A, Guicherit OM, Duret L, Aslanian A, Sanjines EM, Denko NC, Giaccia AJ and Blau HM: Highly conserved RNA sequences that are sensors of environmental stress. Mol Cell Biol 18: 7371-7382, 1998.
32. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta Delta C(T)) Method. Methods 25: 402-408, 2001.
33. Hesketh JE and Pryme IF: Interaction between mRNA, ribosomes and the cytoskeleton. Biochem J 277(Pt 1): 1-10, 1991.
34. Nagy E and Rigby WF: Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J Biol Chem 270: 2755-2763, 1995.
35. Bonafé N, Gilmore-Hebert M, Folk NL, Azodi M, Zhou Y and Chambers SK: Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3′ untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype. Cancer Res 65: 3762-3771, 2005.
36. Wilson GM and Brewer G: The search for trans-acting factors controlling messenger RNA decay. Prog Nucleic Acid Res Mol Biol 62: 257-291, 1999.
37. Lau PP, Zhu HJ, Nakamuta M and Chan L: Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing. J Biol Chem 272: 1452-1455, 1997.
38. Piñol-Roma S and Dreyfuss G: Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 355: 730-732, 1992.
39. Matunis MJ, Xing J and Dreyfuss G: The hnRNP F protein: unique primary structure, nucleic acid-binding properties, and subcellular localization. Nucleic Acids Res 22: 1059-1067, 1994.